Health In Tech, Inc. filed a Form 8-K on November 12, 2026, reporting the voting results from its 2026 Annual Meeting of Stockholders held on November 10, 2026, at which stockholders approved all five proposals submitted to a vote.

Key Highlights

  • Quorum achieved: Stockholders holding an aggregate of 154,451,428 votes were present in person or by proxy, representing approximately 90.53% of the outstanding voting power.
  • All five directors elected: Tim Johnson, Julia (LinLin) Qian, William D. Howard, Timothy Hayes, and new nominee Tim Cortes were each elected to serve until the 2027 annual meeting.
  • Authorized shares expanded: Stockholders approved an increase in total authorized capital stock from 220,000,000 to 720,000,000 shares, comprised of 650,000,000 Class A, 50,000,000 Class B, and 20,000,000 Series A Preferred shares.
  • Equity Incentive Plan expanded: The shares authorized under the Health In Tech, Inc. Equity Incentive Plan (2024) were increased from 10,677,849 to 30,677,849 shares, with the incentive stock option limit raised to 13,000,000 shares.
  • Standby Equity Purchase Agreement approved: Stockholders approved issuances under the Standby Equity Purchase Agreement dated August 12, 2026, between the company and YA II PN, Ltd., in compliance with Nasdaq Listing Rules 5635(b) and 5635(d).
  • Auditors ratified: MaloneBailey, LLP was ratified as independent auditors for the fiscal year ending December 31, 2026, receiving 154,368,145 votes in favor.

Health In Tech 2026 Annual Meeting Voting Results in Detail

According to the Form 8-K filed by Health In Tech, Inc. (NASDAQ:HIT) on November 12, 2026, the company held its 2026 Annual Meeting of Stockholders on November 10, 2026. As of the record date of September 18, 2026, there were 65,300,790 shares of common stock issued and outstanding, consisting of 53,600,790 shares of Class A common stock and 11,700,000 shares of Class B common stock. Each Class A share carried one vote per share and each Class B share carried ten votes per share, the filing disclosed.

The filing noted that the Board of Directors approved a revision to Proposal Four on October 27, 2026, changing the proposed share increase under the Equity Incentive Plan (2024) to 30,677,849 total shares from the originally proposed 20,677,849 shares. As described in the filing, all proxies submitted prior to the October 28, 2026 supplement to the proxy statement were disregarded and not counted, and the voting results reported reflect only proxies and voting instructions submitted after that supplement's date. Director Tim Cortes received the highest "For" vote count among the five nominees, with 154,365,320 votes in favor, while Julia (LinLin) Qian received 151,163,957 votes in favor, according to the filing.

The proposal to approve issuances under the Standby Equity Purchase Agreement with YA II PN, Ltd., dated August 12, 2026, received 154,080,077 votes in favor and 353,180 against, the company disclosed. The amendment to increase authorized capital stock received 153,585,457 votes in favor. The Equity Incentive Plan amendment received 153,782,455 votes in favor. All proposals passed with no broker non-votes recorded on any item, according to the filing.

What Was Disclosed

Health In Tech, Inc. reported the results of its November 10, 2026 Annual Meeting, at which stockholders approved all five proposals: election of five directors, an authorized share increase, the standby equity purchase agreement issuances, an equity plan amendment, and auditor ratification.